Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.59 EUR | -1.67% | -9.23% | -34.00% |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | IntegraGen SA Announces Revenue Results for the First Half of 2023 | CI |
Valuation
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|
Capitalization 1 | 17.05 | 16.5 | 7.197 | 6.536 | 13.61 |
Enterprise Value (EV) 1 | 15.82 | 12.9 | 3.768 | 4.017 | 10.5 |
P/E ratio | -10.3 x | -19.1 x | -6.3 x | -23 x | -36.6 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.72 x | 2.53 x | 1.04 x | 0.79 x | 1.51 x |
EV / Revenue | 2.52 x | 1.98 x | 0.54 x | 0.49 x | 1.17 x |
EV / EBITDA | -9.45 x | -7.14 x | -3.61 x | -37.6 x | -375 x |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | 13.3 x | 4.19 x | 2.57 x | 2.61 x | 6.28 x |
Nbr of stocks (in thousands) | 5,030 | 6,495 | 6,484 | 6,471 | 6,638 |
Reference price 2 | 3.390 | 2.540 | 1.110 | 1.010 | 2.050 |
Announcement Date | 17-04-28 | 18-04-27 | 19-03-01 | 20-04-03 | 21-06-11 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|
Net sales 1 | 6.272 | 6.509 | 6.951 | 8.28 | 9 |
EBITDA 1 | -1.673 | -1.807 | -1.043 | -0.107 | -0.028 |
EBIT 1 | -1.779 | -1.93 | -1.179 | -0.3631 | -0.255 |
Operating Margin | -28.36% | -29.65% | -16.97% | -4.38% | -2.83% |
Earnings before Tax (EBT) 1 | -1.921 | -1.195 | -1.333 | -0.4379 | -0.467 |
Net income 1 | -1.651 | -0.8622 | -1.14 | -0.2848 | -0.375 |
Net margin | -26.32% | -13.25% | -16.4% | -3.44% | -4.17% |
EPS 2 | -0.3289 | -0.1330 | -0.1763 | -0.0439 | -0.0559 |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 17-04-28 | 18-04-27 | 19-03-01 | 20-04-03 | 21-06-11 |
Balance Sheet Analysis
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 1.23 | 3.59 | 3.43 | 2.52 | 3.11 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | -78.3% | -33.1% | -33.9% | -10.7% | -16% |
ROA (Net income/ Total Assets) | -13.7% | -14.9% | -8.55% | -2.96% | -2.05% |
Assets 1 | 12.03 | 5.803 | 13.32 | 9.622 | 18.32 |
Book Value Per Share 2 | 0.2600 | 0.6100 | 0.4300 | 0.3900 | 0.3300 |
Cash Flow per Share 2 | 0.1100 | 0.2100 | 0.1100 | 0.1800 | 0.7700 |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 17-04-28 | 18-04-27 | 19-03-01 | 20-04-03 | 21-06-11 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-34.00% | 4.18M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- ALINT Stock
- Financials IntegraGen